Lipoprotein(a) concentration increases during treatment with carbamazepine

Epilepsia

Volumn 44, Issue 3, 2003, Pages 457-460

  Brämswig, Suzanne ^a   Sudhop, Thomas ^a   Luers, Claus ^a   von Bergmann, Klaus ^a   Berthold, Heiner K ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Drug Commn of the Ger Med Assoc   (Germany)

Author keywords

Carbamazepine; Diabetes mellitus; Humans; Lipoprotein(a); Neuropathic pain management

Indexed keywords

ANTICONVULSIVE AGENT; APOLIPOPROTEIN B; CARBAMAZEPINE; CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DIABETIC NEUROPATHIES; HUMANS; LIPOPROTEIN(A); MALE; PROSPECTIVE STUDIES; RISK FACTORS; STIMULATION, CHEMICAL; SUPINE POSITION; TRIGLYCERIDES;

EID: 0037344186     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.44802.x     Document Type: Article

References (18)

1. Brown DW, Ketter TA, Crumlish J, et al. Carbamazepine-induced increases in total serum cholesterol: clinical and theoretical implications. J Clin Psychopharmacol 1992;12:431-7.
2. Isojärvi JI, Pakarinen AJ, Myllyla VV. Serum lipid levels during carbamazepine medication: a prospective study. Arch Neurol 1993; 50:590-3.
3. Zeitlhofer J, Doppelbauer A, Tribl G, et al. Changes of serum lipid patterns during long-term anticonvulsive treatment. Clin Invest 1993;71:574-8.
4. Pita-Calandre E, Rodríguez-López CM, Cano MD, et al. Serum lipids, lipoproteins and apolipoproteins in adult epileptic patients treated with carbamazepine, valproic acid or phenytoin [Spanish]. Rev Neurol 1998;27:785-9.
5. Verrotti A, Basciani F, Domizio S, et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol 1998;19:364-7.
6. Sudhop T, Bauer J, Elger CE, et al. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study. Epilepsia 1999:40:480-4.
7. Eiris J, Novo-Rodriguez MI, Del Rio M, et al. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res 2000;41:1-7.
8. Kark JD, Sandholzer C, Friedlander Y, et al. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis 1993;98:139-51.
9. Schwaninger M, Ringleb P, Annecke A, et al. Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients. J Neurol 2000;247:687-90.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
11. Krempler F, Kostner GM, Balzano K, et al. Turnover of lipoprotein(a) in man. J Clin Invest 1980;65:1483-90.
12. Brämswig S, Kerksiek A, Sudhop T, et al. Lipoprotein kinetics during carbamazepine treatment. Am J Physiol Heart Circ Physiol 2002;282:H704-16.
13. Kronenberg F, Trenkwalder E, Lingenhel A, et al. Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J Lipid Res 1997;38: 1755-63.
14. Sorensen P, Hammer M. Effects of long-term carbamazepine treatment on water metabolism and plasma vasopressin concentration. Eur J Clin Pharmacol 1984;26:719-22.
15. Hoppichler F, Sandholzer C, Moncayo R, et al. Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels. Atherosclerosis 1995; 115:65-71.
16. Tiihonen M, Liewendahl K, Waltimo O, et al. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia 1995;36:1118-25.
17. Eirís-Punal J, Del Río-Garma M, Del Río-Garma MC, et al. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999; 40:1761-6.
18. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-20.